| Product Name | NebuSelect™ Recombinant Human SLPI, hFc-tag |
|---|---|
| Catalog Number | NBL-242087 |
| Alias/Synonyms | SLPI; ALP; BLPI; HUSI-1; MPI; WAP4; WFDC4; ALK1; HUSI; SLPI |
| Appearance | see COA |
| Molecule Weight | Ser26-Ala132 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P03973 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242087-100ug | 100ug | Inquire | Inquire | |
| NBL-242087-1mg | 1mg | Inquire | Inquire | |
| NBL-242087-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human SLPI, hFc-tag
Catalog#:
NBL-242087
Description:
NebuSelect™ Recombinant Human SLPI, hFc-tag(Cat#NBL-242087) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ser26-Ala132.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 38.5 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
SLPI; ALP; BLPI; HUSI-1; MPI; WAP4; WFDC4; ALK1; HUSI; SLPI
Target Information:
Elafin and SLPI (secretory leucocyte protease inhibitor) have multiple important roles both in normal homoeostasis and at sites of inflammation. These include antiprotease and antimicrobial activity as well as modulation of the response to LPS (lipopolysaccharide) stimulation. Elafin and SLPI are members of larger families of proteins secreted predominantly at mucosal sites, and have been shown to be modulated in multiple pathological conditions.
Amino Acid Sequence:
Ser26-Ala132
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.